Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126809342 | 12680934 | 2 | F | 20160801 | 20160926 | 20160824 | 20160927 | PER | US-PFIZER INC-2016394190 | PFIZER | 52.00 | YR | F | Y | 73.00000 | KG | 20160927 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126809342 | 12680934 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY | D | M75907 | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | ||||
| 126809342 | 12680934 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG EVERY OTHER DAY FOR ONE MONTH | D | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QOD | |||||
| 126809342 | 12680934 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, THREE TIMES A WEEK FOR TWO WEEKS | D | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | ||||||
| 126809342 | 12680934 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 2X/WEEK | D | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | BIW | |||||
| 126809342 | 12680934 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 1 DF (MAYBE 1 MG), 1X/DAY | 0 | 1 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126809342 | 12680934 | 1 | Anxiety |
| 126809342 | 12680934 | 2 | Depression |
| 126809342 | 12680934 | 5 | Hypothyroidism |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126809342 | 12680934 | Abdominal pain upper | |
| 126809342 | 12680934 | Disturbance in attention | |
| 126809342 | 12680934 | Emotional disorder | |
| 126809342 | 12680934 | Feeling abnormal | |
| 126809342 | 12680934 | Headache | |
| 126809342 | 12680934 | Memory impairment | |
| 126809342 | 12680934 | Nausea | |
| 126809342 | 12680934 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126809342 | 12680934 | 1 | 2012 | 20160615 | 0 | |
| 126809342 | 12680934 | 2 | 20160615 | 20160715 | 0 | |
| 126809342 | 12680934 | 3 | 20160715 | 0 | ||
| 126809342 | 12680934 | 4 | 20160812 | 0 | ||
| 126809342 | 12680934 | 5 | 2010 | 0 |